Page last updated: 2024-08-18

cyclohexanol and formaldehyde

cyclohexanol has been researched along with formaldehyde in 10 studies

Research

Studies (10)

TimeframeStudies, this research(%)All Research%
pre-19901 (10.00)18.7374
1990's0 (0.00)18.2507
2000's5 (50.00)29.6817
2010's4 (40.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kremko, LM; Pavliutina, ZN; Pertsovskiĭ, AL; Vilisov, BA1
Jester, JV; Li, L; Maurer, JK; Molai, A1
Lewis, BE; Schramm, VL1
Hemrick-Luecke, SK; Iyengar, S; Simmons, RM; Webster, AA; Xu, JY1
Khodayar, MJ; Naderi, N; Shafaghi, B; Zarindast, MR1
Khodayar, MJ; Naderi, N; Shafaghi, B; Zarrindast, MR1
Bolognini, D; Cascio, MG; Corelli, F; Di Marzo, V; Maione, S; Palazzo, E; Pasquini, S; Pertwee, RG1
de Almeida, RN; de Sousa, DP; Fonsêca, DV; Monte, LO; Salgado, PR; Souto-Maior, FN1
Anan, K; Hara, S; Hasebe, N; Kai, H; Kume, M; Masui, M; Ohara, M; Shimada, S; Shinohara, S; Tsuji, H; Yagi, S; Yamamoto, S1
Henderson-Redmond, AN; LaFleur, RA; Morgan, DJ; Wilson, RP1

Other Studies

10 other study(ies) available for cyclohexanol and formaldehyde

ArticleYear
[Significance of chemical admixtures to bricks during their production].
    Gigiena truda i professional'nye zabolevaniia, 1982, Issue:11

    Topics: Adipates; Air Pollutants; Air Pollutants, Occupational; Construction Materials; Cyclohexanols; Formaldehyde; Humans; Methanol

1982
Extent of initial corneal injury as a basis for alternative eye irritation tests.
    Toxicology in vitro : an international journal published in association with BIBRA, 2001, Volume: 15, Issue:2

    Topics: Acetic Acid; Acetone; Animal Testing Alternatives; Animals; Coloring Agents; Cornea; Cyclohexanols; Eye; Fluoresceins; Formaldehyde; Irritants; Microscopy, Confocal; Predictive Value of Tests; Rabbits; Sodium Hydroxide; Surface-Active Agents; Toxicity Tests

2001
Binding equilibrium isotope effects for glucose at the catalytic domain of human brain hexokinase.
    Journal of the American Chemical Society, 2003, Apr-23, Volume: 125, Issue:16

    Topics: 2-Propanol; Brain; Catalytic Domain; Computer Simulation; Cyclohexanols; Enzyme Activation; Ethanol; Formaldehyde; Glucose; Hexokinase; Humans; Hydrogen Bonding; Kinetics; Methane; Models, Molecular; Molecular Conformation; Protein Structure, Tertiary; Pyrans; Tritium

2003
Efficacy of duloxetine, a potent and balanced serotonin-norepinephrine reuptake inhibitor in persistent pain models in rats.
    The Journal of pharmacology and experimental therapeutics, 2004, Volume: 311, Issue:2

    Topics: Acute Disease; Amines; Amitriptyline; Animals; Conscious Sedation; Cyclohexanecarboxylic Acids; Cyclohexanols; Cyclopropanes; Disease Models, Animal; Drug Therapy, Combination; Duloxetine Hydrochloride; Fluoxetine; Formaldehyde; Gabapentin; gamma-Aminobutyric Acid; Male; Methyltyrosines; Milnacipran; Neuromuscular Junction; Norepinephrine; p-Chloroamphetamine; Pain; Paroxetine; Rats; Rats, Sprague-Dawley; Serotonin; Thiophenes; Venlafaxine Hydrochloride

2004
Interaction between gamma-aminobutyric acid GABAB and cannabinoid CB1 receptors in spinal pain pathways in rat.
    European journal of pharmacology, 2005, May-09, Volume: 514, Issue:2-3

    Topics: Analysis of Variance; Animals; Baclofen; Cyclohexanols; Dose-Response Relationship, Drug; Drug Interactions; Formaldehyde; GABA Agonists; GABA Antagonists; GABA-B Receptor Agonists; GABA-B Receptor Antagonists; Injections, Spinal; Male; Pain; Piperidines; Pyrazoles; Rats; Rats, Wistar; Receptor, Cannabinoid, CB1; Receptors, GABA-B; Rimonabant; Signal Transduction; Spinal Cord

2005
Antinociceptive effect of spinally administered cannabinergic and 2-adrenoceptor drugs on the formalin test in rat: possible interactions.
    Journal of psychopharmacology (Oxford, England), 2006, Volume: 20, Issue:1

    Topics: Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Analgesics; Animals; Cyclohexanols; Formaldehyde; Injections, Spinal; Male; Pain Measurement; Piperidines; Pyrazoles; Rats; Rats, Wistar; Receptor, Cannabinoid, CB1; Receptors, Adrenergic, alpha-2; Receptors, Cannabinoid; Rimonabant; Spinal Cord; Yohimbine

2006
In vitro and in vivo pharmacological characterization of two novel selective cannabinoid CB(2) receptor inverse agonists.
    Pharmacological research, 2010, Volume: 61, Issue:4

    Topics: Analgesics; Animals; CHO Cells; Cricetinae; Cricetulus; Cyclohexanols; Drug Inverse Agonism; Formaldehyde; Guanosine 5'-O-(3-Thiotriphosphate); Mice; Molecular Structure; Pain; Quinolones; Radioligand Assay; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Structure-Activity Relationship

2010
Antinociceptive and anticonvulsant effects of the monoterpene linalool oxide.
    Pharmaceutical biology, 2017, Volume: 55, Issue:1

    Topics: Acetic Acid; Acyclic Monoterpenes; Analgesics; Animals; Anticonvulsants; Behavior, Animal; Cyclohexanols; Disease Models, Animal; Dose-Response Relationship, Drug; Electroshock; Formaldehyde; Lethal Dose 50; Male; Mice; Monoterpenes; Motor Activity; Nociception; Nociceptive Pain; Pentylenetetrazole; Reaction Time; Rotarod Performance Test; Seizures; Time Factors; Trityl Compounds

2017
Discovery of orally bioavailable cyclohexanol-based NR2B-selective NMDA receptor antagonists with analgesic activity utilizing a scaffold hopping approach.
    Bioorganic & medicinal chemistry letters, 2017, 09-01, Volume: 27, Issue:17

    Topics: Administration, Oral; Analgesics; Animals; Brain; Cyclohexanols; Dose-Response Relationship, Drug; Drug Discovery; Formaldehyde; HEK293 Cells; Humans; Mice; Molecular Structure; Pain; Rats; Receptors, N-Methyl-D-Aspartate; Structure-Activity Relationship

2017
Sex differences in antinociceptive response to Δ-9-tetrahydrocannabinol and CP 55,940 in the mouse formalin test.
    Neuroreport, 2018, 04-11, Volume: 29, Issue:6

    Topics: Analgesics; Analysis of Variance; Animals; Cyclohexanols; Disease Models, Animal; Dose-Response Relationship, Drug; Dronabinol; Drug Tolerance; Female; Formaldehyde; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Mutation; Pain; Pain Measurement; Receptor, Cannabinoid, CB1; Sex Characteristics; Time Factors; Treatment Outcome

2018